drugset / Trial / NCT00959634

Pharmacokinetic Study of ABT-126 in Healthy Volunteers

NCT00959634

Phase 1 Completed 20 enrolled Abbott
RandomizedSingle-groupDouble-blindTreatment

Summary

This is a study to investigate the process by which ABT-126 is absorbed, distributed, metabolized and eliminated by the body of a healthy volunteer.

Timeline

Start
2009-08
Primary completion
2009-09
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject ABT-126 Small molecule

Indications

No indication recorded.